Evidence map›Paper›PMID 40100903›Full record

ArticlePloS one2025

Coronavirus disease 2019 (COVID-19) vaccine acceptability in Ghana: An urban-based population study.

Hannah Benedicta Taylor-Abdulai, Edem Kojo Dzantor, Nathan Kumasenu Mensah, Mubarick Nungbaso Asumah, Stephen Ocansey, Samuel Kofi Arhin, Precious Barnes, Victor Obiri Opoku, Zakariah Jirimah Mankir, Sylvester Ackah Famieh and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hannah Benedicta Taylor-AbdulaiDepartment of Physician Assistant Studies, School of Allied Health Sciences, University of Cape Coast, Cape Coast, Ghana.
Edem Kojo DzantorDepartment of Epidemiology and Biostatistics, Fred N. Binka School of Public Health, University of Health and Allied Sciences, Hohoe Campus, Hohoe, Ghana.
Nathan Kumasenu MensahDepartment of Health Information Management, School of Allied Health Sciences, University of Cape Coast, Cape Coast, Ghana.ORCID https://orcid.org/0000-0001-5333-589X
Mubarick Nungbaso AsumahNurses and Midwifery Training College, Ministry of Health, Tamale, Ghana.
Stephen OcanseyDepartment of Physician Assistant Studies, School of Allied Health Sciences, University of Cape Coast, Cape Coast, Ghana.
Samuel Kofi ArhinDepartment of Physician Assistant Studies, School of Allied Health Sciences, University of Cape Coast, Cape Coast, Ghana.
Precious BarnesDepartment of Physician Assistant Studies, School of Allied Health Sciences, University of Cape Coast, Cape Coast, Ghana.
Victor Obiri OpokuDepartment of Physician Assistant Studies, School of Allied Health Sciences, University of Cape Coast, Cape Coast, Ghana.
Zakariah Jirimah MankirDepartment of Physician Assistant Studies, School of Allied Health Sciences, University of Cape Coast, Cape Coast, Ghana.
Sylvester Ackah FamiehDepartment of Physician Assistant Studies, School of Allied Health Sciences, University of Cape Coast, Cape Coast, Ghana.
Collins Paa Kwesi BotcheyDepartment of Physician Assistant Studies, School of Allied Health Sciences, University of Cape Coast, Cape Coast, Ghana.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCoronavirus disease 2019 (COVID-19) vaccine hesitancy is a complex health challenge characterized by a delay in the acceptance or refusal of the vaccination with context-specific determinants. Our study, therefore, assessed the COVID-19 vaccine acceptance among urban dwellers in the Central Region, of Ghana.

methodsA cross sectional study was conducted between September and November, 2022 using a multi-stage cluster sampling procedure among 377 participants. A modified World Health Organization pretested paper-based questionnaire was administered to study participants. The data was analyzed using Statistical Package for Social Sciences (SPSS) version 26. Descriptive and inferential statistics were carried out and results were summarized into frequencies, percentages, tables, and charts for clarity. A conventional p-value < 0.05 was considered statistically significant.

resultsThe study revealed that COVID-19 vaccine acceptance was 20.0% (76/377) and vaccine hesitancy was 80.0% (301/377). Out of the 377 participants, their socio-demographic characteristics showed that the majority were below 25 years 53.8% (203/377), [vaccine acceptance; 36.84% (28/76) vs vaccine hesitancy; 58.14% (175/301)], and females 50.1% (189/377), [vaccine acceptance; 56.58% (43/76) vs vaccine hesitancy; 48.50% (146/301)]. Common reasons for COVID-19 vaccine hesitancy included mistrust of the source of the vaccine, personal belief and experience, mistrust of the drug development process, mistrust in the health system, and mistrust of the pharmaceutical company. Age above 25 years, female, educational levels, senior high school and above, being employed, and hearing of new vaccine had a significance influence on COVID-19 vaccine acceptance.

conclusionCOVID-19 vaccine acceptance was low with high vaccine hesitancy among participants. The study's findings highlights the importance of addressing vaccine hesitancy through building trust in the vaccine development processes, including the provision of accurate information about the vaccine safety and efficacy. Resolving concerns related to the source of the vaccine and the overall healthcare system are important to address vaccine hesitancy. Policy makers could adopt tailored interventions targeting specific demographic groups, such as the younger population and females to increase vaccine acceptance. Ghana's public health authorities could adopt the findings to re-strategize its urban COVID-19 vaccine campaigns to address misconceptions and misinformation to increase vaccine acceptance.

Indexed as

COVID-19COVID-19 VaccinesPatient Acceptance of Health CareVaccination HesitancyAdolescentAdultAgedCross-Sectional StudiesFemaleGhanaHumansMaleMiddle AgedSARS-CoV-2Surveys and QuestionnairesUrban PopulationCOVID-19 Vaccines

Identifiers

PMID40100903
PMCPMC11918374

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.